The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 13, 2017

Filed:

Apr. 13, 2016
Applicant:

Thevax Genetics Vaccine Co., Ltd., Taipei, TW;

Inventors:

Wei-I Chou, Hsinchu County, TW;

Chia-Mao Wu, Hsinchu County, TW;

Jiun-Ming Wu, Hsinchu County, TW;

Hsiu-Kang Chang, Taipei, TW;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/21 (2006.01); C07K 19/00 (2006.01); A61K 39/02 (2006.01); A61K 39/385 (2006.01); A61K 39/21 (2006.01); C07K 14/005 (2006.01); A61K 47/48 (2006.01); C07K 14/705 (2006.01); A61K 39/12 (2006.01); A61K 39/135 (2006.01); A61K 39/17 (2006.01); C07K 14/81 (2006.01); C12N 9/10 (2006.01); C12N 9/14 (2006.01); A61K 39/29 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/12 (2013.01); A61K 39/135 (2013.01); A61K 39/17 (2013.01); A61K 39/21 (2013.01); A61K 39/29 (2013.01); A61K 39/292 (2013.01); A61K 39/385 (2013.01); A61K 47/4833 (2013.01); C07K 14/70596 (2013.01); C07K 14/81 (2013.01); C12N 9/1077 (2013.01); C12N 9/14 (2013.01); C12Y 204/02036 (2013.01); C12Y 306/05002 (2013.01); A61K 2039/57 (2013.01); A61K 2039/585 (2013.01); A61K 2039/6031 (2013.01); C07K 14/21 (2013.01); C07K 2319/02 (2013.01); C07K 2319/04 (2013.01); C07K 2319/095 (2013.01); C07K 2319/33 (2013.01); C07K 2319/40 (2013.01); C07K 2319/55 (2013.01); C12N 2710/20022 (2013.01); C12N 2710/20034 (2013.01); C12N 2730/10122 (2013.01); C12N 2730/10134 (2013.01); C12N 2750/10022 (2013.01); C12N 2750/10034 (2013.01); C12N 2760/18134 (2013.01); C12N 2770/24222 (2013.01); C12N 2770/24234 (2013.01); C12N 2770/24334 (2013.01); C12N 2770/32134 (2013.01);
Abstract

A vaccine composition comprising a fusion protein for inducing enhanced pathogen antigen-specific T cell responses is disclosed. The fusion protein comprises: (a) an antigen-presenting cell (APC)-binding domain or a CD91 receptor-binding domain, located at the N-terminus of the fusion protein; (b) a translocation peptide of 34-112 amino acid residues in length, comprising an amino acid sequence that is at least 90% identical to SEQ ID NO: 4, 2, 3, or 6, located at the C-terminus of the APC-binding domain or the CD91 receptor-binding domain; and (c) an antigen of a pathogen, located at the C-terminus of the translocation peptide; (d) a nuclear export signal, comprising the amino acid sequence of SEQ ID NO: 13; and (e) an endoplasmic reticulum retention sequence, located at the C-terminus of the fusion protein.


Find Patent Forward Citations

Loading…